LMNA and Parkinson disease: The evidence here, along with previous work showing progerin-induced aging can uncover phenotypes in iPSC-derived neurons from Parkinson’s disease patients (Miller et al., 2013), provides a rationale for using progerin-induced aging as a paradigm to enhance phenotypes in HD and other age-dependent neurodegenerative diseases.